Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Times Interest Earned (2016 - 2017)

IGC Pharma has reported Times Interest Earned over the past 8 years, most recently at -$7.81 for Q4 2017.

  • Quarterly Times Interest Earned rose 5.96% to -$7.81 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$3.09 through Sep 2018, up 62.02% year-over-year, with the annual reading at -$9.19 for FY2017, 32.32% up from the prior year.
  • Times Interest Earned was -$7.81 for Q4 2017 at IGC Pharma, down from -$6.44 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $9.87 in Q1 2015 and troughed at -$52.04 in Q1 2016.
  • The 5-year median for Times Interest Earned is -$7.45 (2015), against an average of -$8.84.
  • Year-over-year, Times Interest Earned tumbled 1226.5% in 2013 and then skyrocketed 1299.32% in 2015.
  • A 5-year view of Times Interest Earned shows it stood at -$5.6 in 2013, then tumbled by 43.86% to -$8.06 in 2014, then rose by 8.73% to -$7.35 in 2015, then decreased by 13.01% to -$8.31 in 2016, then increased by 5.96% to -$7.81 in 2017.
  • Per Business Quant, the three most recent readings for IGC's Times Interest Earned are -$7.81 (Q4 2017), -$6.44 (Q3 2017), and -$8.9 (Q2 2017).